Personal information

Activities

Funding (7)

Hallas Møller Ascending Investigator

2021 to 2026 | Grant
Novo Nordisk (Denmark) (Copenhagen, DK)
Source: Self-asserted source
Paolo Ceppi

Molecular characterization and targeting of NSCLC with high thymidylate synthase (TS) levels

2020 to 2023 | Grant
Danish National Research Foundation (Copenhagen, DK)
Source: Self-asserted source
Paolo Ceppi

Deciphering and targeting the metabolic control of lung cancer de differentiation

2019 to 2022 | Grant
Deutsche Forschungsgemeinschaft (Bonn, DE)
Source: Self-asserted source
Paolo Ceppi

Whole genome CRISPR/Cas9 mediated identification of miR 200 repressors

2018 to 2021 | Grant
Deutsche Forschungsgemeinschaft (Bonn, DE)
Source: Self-asserted source
Paolo Ceppi

The role of AKR1B1 in cancer cells epithelial to mesenchymal transition

2017 to 2020 | Grant
Deutsche Krebshilfe (Bonn, DE)
GRANT_NUMBER:

70112536

Source: Self-asserted source
Paolo Ceppi

The role of thymidylate synthase in epithelial to mesenchymal transition in NSCLC

2017 to 2018 | Salary award
International Association for the Study of Lung Cancer (CO, CO, US)
Source: Self-asserted source
Paolo Ceppi

Fas Protects Breast Cancer Stem Cells from Death

2013 to 2015 | Grant
U.S. Department of Defense (DC, DC, US)
GRANT_NUMBER:

ADA613359

Source: Self-asserted source
Paolo Ceppi

Peer review (1 review for 1 publication/grant)

Review activity for Cell reports. (1)